H.R. 5605 · 115th Congress
Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Passed the House without a recorded vote, then expired. It passed by voice vote or unanimous consent, which don't record how each member voted, but didn't become law before the 115th Congress ended.
D
RuizSponsor2 cosponsors · 2 R
0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
- House Introduced Apr 24, 2018
- House Passed Jun 19, 2018
Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act
What it does: CRS summary · Passed House amended · Jun 19, 2018
Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act
(Sec. 2) This bill requires the Centers for Medicare & Medicaid Services (CMS) to carry out a demonstration program to: (1) increase access to opioid-use disorder treatment services for Medicare beneficiaries, (2) improve physical and mental health outcomes for such beneficiaries, and (3) reduce Medicare expenditures.
Opioid-use disorder care teams of practitioners may apply for participation in the demonstration project. The CMS must establish a performance-based incentive payment for participants.
(Sec. 3) The bill also requires prescriptions for controlled substances that are covered under the Medicare prescription drug benefit or Medicare Advantage prescription drug plans to be transmitted via electronic prescription programs. The CMS may waive such requirements under specified circumstances.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Advancing High Quality Treatment for Opioid Use Disorders in Medicare Act
Latest action (Jun 20, 2018): Received in the Senate and Read twice and referred to the Committee on Finance.
Policy area: Health · Origin: House · Introduced: Apr 24, 2018
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
- House Introduced Apr 24, 2018
- House Passed Jun 19, 2018
No recorded floor vote found.